China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment HBANL Q1 2026 Earnings Preferred Dividend Misses Estimates on Higher Provisioning HEPS Q1 2026 Earnings Negative EPS Weighs on Stock Amid Ongoing Operational Challenges EYE Q1 2026 Earnings Earnings Beat Estimates Stock Moves Higher RVMD Q1 2026 Earnings EPS Miss Signals Higher RD Spending Amid LateStage Pipeline Push LFMD Q1 2026 Earnings EPS Surprise Lifts Sentiment Despite Disclosed Revenue Uncertainty